Vaccines – Page 5

GSK’s Penmenvy Approved: New 5-in-1 Meningococcal Vaccine Enters U.S. Market

4 months ago talkbio0Tagged Approved, Invasive meningococcal disease, MenABCWY, Meningococcal vaccine, Penmenvy, SmithKline Beecham, United States Food and Drug Administration, Vaccines

Penmenvy, GSK, meningococcal vaccine, FDA approval, 5-in-1 vaccine, MenABCWY, invasive meningococcal disease (IMD)

GSK’s Penmenvy Gains FDA Approval, Joining Pfizer in 5-in-1 Meningococcal Vaccine Market

4 months ago talkbio0Tagged Adolescent (age group), Approved, Invasive meningococcal disease, Meningococcal vaccine, Penmenvy, Pfizer, SmithKline Beecham, United States Food and Drug Administration, Vaccines, Young Adult

Penmenvy, GSK, FDA approval, meningococcal vaccine, 5-in-1 vaccine, Pfizer, Penbraya, invasive meningococcal disease (IMD), adolescents and young adults

Robert F. Kennedy Jr. Confirmed as HHS Secretary in Close Senate Vote

4 months ago talkbio0Tagged Administration occupational activities, CHARGE Syndrome, Confirmation, Health Policy, Healthy, RFK Jr., Secretary, Senate, Skepticism, Transplant Registry Unified Management Program, Vaccines

RFK Jr., HHS Secretary, Senate confirmation, Trump administration, vaccine skepticism, healthcare policy, Make America Healthy Again

Sanofi and Johnson & Johnson’s E. coli Vaccine Candidate Fails in Phase 3 Trial

4 months ago talkbio0Tagged E. coli disease, Escherichia coli, ExPEC9V, Failure (biologic function), Invasive, Johnson & Johnson, Phase 3 trial, sanofi, Vaccines

E. coli vaccine, Sanofi, Johnson & Johnson, Phase 3 trial failure, invasive E. coli disease, ExPEC9V

Sanofi’s E. coli Vaccine Fails Phase 3 Trial, Resulting in $250M Impairment Charge

4 months ago talkbio0Tagged charge amounts, Clinical Trials, Escherichia coli, Failure (biologic function), Impaired, Johnson & Johnson, Phase 3, sanofi, Vaccines

Sanofi, Johnson & Johnson, E. coli vaccine, Phase 3 failure, impairment charge, clinical trial discontinuation

RFK Jr. Dodges Vaccine-Autism Questions in Senate Confirmation Responses

4 months ago talkbio0Tagged Autistic Disorder, CHARGE Syndrome, Confirmation, Hearings, Misinformation, Response process, Robert F. Kennedy, Secretary Nomination, Senate, Vaccines, Written - Consent Mode

Robert F. Kennedy Jr., HHS Secretary nomination, vaccine misinformation, autism, Senate confirmation hearings, written responses

RFK Jr.’s HHS Secretary Nomination Advances to Full Senate Vote

4 months ago talkbio0Tagged CHARGE Syndrome, Confirmation, Republican, Robert F. Kennedy, Secretary, Senate Finance Committee, Vaccines

Robert F. Kennedy Jr., HHS Secretary, Senate Finance Committee, confirmation process, vaccine controversy, Republican support

Senator Cassidy’s Crucial Vote Advances RFK Jr.’s HHS Secretary Nomination

4 months ago talkbio0Tagged Administration occupational activities, Bill Cassidy, CHARGE Syndrome, HHS, public health medicine (field), Robert F. Kennedy, Secretary Nomination, Senate Finance Committee, Transplant Registry Unified Management Program, Vaccines

Robert F. Kennedy Jr., Bill Cassidy, HHS Secretary nomination, Senate Finance Committee, vaccine safety, public health, Trump administration

AstraZeneca Cancels £450 Million UK Vaccine Plant Expansion Amid Government Funding Reduction

4 months ago talkbio0Tagged Administration occupational activities, AstraZeneca, Drug Industry, Economic Growth, Government, Investments, Labor (Childbirth), Manufacturing, UK, Vaccines

AstraZeneca, vaccine manufacturing, UK investment, government funding, Labour administration, economic growth, pharmaceutical industry

Senate Grills RFK Jr. on Controversial Health Stances in Contentious HHS Secretary Confirmation Hearings

4 months ago talkbio0Tagged Administration occupational activities, CHARGE Syndrome, Chronic disease, Confirmation, Hearings, public health policy, Robert F. Kennedy, Secretary Nomination, Senate, Skepticism, Transplant Registry Unified Management Program, Vaccines

Robert F. Kennedy Jr., HHS Secretary nomination, Senate confirmation hearings, vaccine skepticism, chronic disease focus, public health policy, Trump administration